IPO Boutique

Black Diamond Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Black Diamond Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Black Diamond Therapeutics, Inc.BDTX -
NASDAQ
$16.00-$18.00 $19.00 $33.0010.6 million1/30/2020
JP Morgan, Jefferies, Cowen
Co-Manager(s):
Canaccord Genuity
Health Care
Filing(s):

Filed 2020-01-03
Terms Added 2020-01-21



Black Diamond Therapeutics, Inc. Quote & Chart - Click for current quote - BDTX

About Black Diamond Therapeutics, Inc. (adapted from Black Diamond Therapeutics, Inc. prospectus):
They are a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "BDTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved